Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Migraine-associated dizziness.

F M Cutrer1, R W Baloh

  • 1Department of Neurology, Reed Neurological Research Center, UCLA School of Medicine 90024-1769.

Headache
|June 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolated dizziness in vertebrobasilar insufficiency: Clinical features, angiography, and follow-up.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Same author

Clinical translation: targeting cortical spreading depression.

Cephalalgia : an international journal of headache·2010
Same author

Botulinum toxin treatment of cephalalgia alopecia increases substance P and calcitonin gene-related peptide-containing cutaneous nerves in scalp.

Cephalalgia : an international journal of headache·2009
Same author

Pain relief and persistence of dysautonomic features in a patient with hemicrania continua responsive to botulinum toxin type A.

Cephalalgia : an international journal of headache·2009
Same author

Association of benign recurrent vertigo and migraine in 208 patients.

Cephalalgia : an international journal of headache·2009
Same author

Practice parameter: therapies for benign paroxysmal positional vertigo (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Neurology·2008
Same journal

Weight loss with atogepant in the long-term treatment of migraine: An interim analysis of a safety endpoint from a phase 3, multicenter, open-label, 156-week extension study.

Headache·2026
Same journal

American Headache Society 68th Annual Scientific Meeting June 4-7, 2026, Orlando, Florida.

Headache·2026
Same journal

In Memoriam-Doctor J. Keith Campbell.

Headache·2026
Same journal

Hypothalamus as a conductor of the migraine prodrome: A narrative review.

Headache·2026
Same journal

New academic year in Headache.

Headache·2026
Same journal

Essential readings in headache medicine: Top 10 educational articles from 2025.

Headache·2026
See all related articles

Migraine-associated dizziness involves nausea, motion sensitivity, and instability. Two mechanisms are proposed: short attacks linked to migraine aura, and longer vertigo episodes from neuroactive peptides affecting vestibular systems.

Area of Science:

  • Neurology
  • Otolaryngology
  • Vestibular Science

Background:

  • Migraine is frequently associated with dizziness, yet its underlying pathophysiology remains incompletely understood.
  • Understanding the vestibular system's role in migraine is crucial for effective patient management.

Observation:

  • A review of 91 patients with migraine-associated dizziness revealed accompanying symptoms like nausea, vomiting, motion hypersensitivity, and postural instability.
  • The temporal pattern of dizziness often correlated more closely with the headache phase than the aura phase of migraine.
  • Quantitative vestibular testing showed unilateral hypoexcitability in 20.9% of patients, suggesting a potential risk to the peripheral vestibular apparatus.

Findings:

  • Two distinct pathophysiological mechanisms for migraine-related dizziness are proposed.

Related Experiment Videos

  • Short-duration vertiginous attacks (minutes to 2 hours), associated with headache, may stem from mechanisms similar to migraine aura, such as spreading depression or vasospasm.
  • Longer-duration vertigo and motion sickness (lasting days), with or without headache, are hypothesized to result from neuroactive peptide release impacting peripheral and central vestibular structures, increasing neuronal firing and motion sensitivity.

    • Implications:

    • This research offers a dual pathophysiological model for migraine-associated dizziness, differentiating short and long-duration episodes.
    • The findings suggest that interventions targeting migraine aura mechanisms might benefit short-duration dizziness, while those addressing neuroactive peptide pathways could help longer episodes.
    • Further research into vestibular system involvement in migraine can lead to improved diagnostic criteria and targeted therapeutic strategies for patients experiencing dizziness.